HSBC Holdings
ALDR

HSBC Holdings’s Alder Biopharmaceuticals ALDR Stock Holding History

HSBC Holdings’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17,183
Closed -$176K – 2968
2018
Q4 		$176K Buy
+17,183
New +$220K ﹤0.01% 2495
2017
Q1 		– Sell
-10,480
Closed -$218K – 2767
2016
Q4 		$218K Buy
+10,480
New +$273K ﹤0.01% 2477

Other funds holding ALDR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

HSBC Holdings's ALDR Position: Q1 2019 in Review

HSBC Holdings sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 17,183 shares — an estimated $176K sold.

HSBC Holdings first reported a position in ALDR in Q4 2016 and held it in 2 quarters. The position peaked at $218K in Q4 2016. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

  • HSBC Holdings reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • HSBC Holdings sold 17,183 Alder Biopharmaceuticals shares in Q1 2019, an estimated $176K.
  • HSBC Holdings first reported a position in Alder Biopharmaceuticals in Q4 2016 and held it in 2 quarters.
  • HSBC Holdings's Alder Biopharmaceuticals position peaked at $218K in Q4 2016.
  • 123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on HSBC Holdings's 13F filing for Q1 2019, filed 15 May 2019.